EnsiliTech

Creating biologicals without refrigeration

  • Biotech
Therapeutics

Member

Active

Status

2022

Founded

Development stage

  • St Philips
    Incubator residents

EnsiliTech is improving the shelf-life and global accessibility of vaccines and other biological therapeutics by combatting cold chain transport and storage issues. Its novel ensilication technology, designed for both existing and new biopharmaceutical formulations, encases thermally unstable biomolecules within silica nanoshells to prevent environmental degradation. This eliminates the need for cold chain requirements that are expensive, prone to failure and generate significant carbon dioxide emissions.

Founding team

Key contacts

Business Development & Operations

Arrow Right Corner
Arrow Right Corner

|